Concepedia

PDE-10A inhibitors as insulin secretagogues

Louis‐David Cantin, Steven Magnuson, David Gunn, Nicole Barucci, Marina Breuhaus, William H. Bullock, Jennifer Burke, Thomas H. Claus, Michelle Daly, Lynn B. DeCarr,

Bioorganic & Medicinal Chemistry Letters · 2007 · 35 citations · 6 references

DOIFull text

Open access

Concepts

References

6

Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes

Expert Opinion on Investigational Drugs · 2003 · 208 citations

, , +17

Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes

Daniel J. Drucker · Expert Opinion on Investigational Drugs · 2003 · 204 citations

, , +17

The Calcium/Calmodulin-dependent Phosphodiesterase PDE1C Down-regulates Glucose-induced Insulin Secretion

Ping Han, John Werber, Manju Surana et al. · Journal of Biological Chemistry · 1999 · 100 citations · Full text

, , +10

Dipeptidyl peptidase IV inhibitors for the treatment of impaired glucose tolerance and type 2 diabetes.

Paul E. Wiedeman, James M. Trevillyan · PubMed · 2003 · 64 citations

, , +17

Effects of type‐selective phosphodiesterase inhibitors on glucose‐induced insulin secretion and islet phosphodiesterase activity

Reza Shafiee-Nick, Nigel J. Pyne, B L Furman · British Journal of Pharmacology · 1995 · 49 citations · Full text

, , +15